by Truveta staff | Jan 10, 2023 | Technology
The key to any disease study is rich data. We recently met with the CEO of a biotech company that specializes in the development of immunotherapies. He and his team had tried to recruit patients for a series of clinical trials related to several rare disease...
by Truveta staff | Nov 21, 2022 | Culture
“I always wanted to live in a lifetime where there is a cure for diabetes, for myself and my family.” At Truveta, we enjoy showcasing our employees and partners, and their connection to our vision, saving lives with data. We believe that a connection to our vision is...
by Truveta staff | Nov 18, 2022 | News, Research
Last week, two members of Truveta Research — Dr. Charlotte Baker, DrPH, MPH, CPH, and Dr. Peter Smits, PhD — attended the 150th Annual Meeting of the American Public Health Association (APHA) in Boston. Dr. Peter Smits presented on Truveta Research’s...
by Truveta staff | Nov 17, 2022 | News, Technology
Truveta held a LinkedIn Live on November 16th to catch everyone up on our latest product announcement, Truveta Studio, and share insights from a few members of Truveta Research. If you missed it, watch it now, and check out some of the highlights below: VP of...
by Truveta staff | Nov 10, 2022 | Research
Earlier this year, Truveta Research presented insights from the start of the pandemic, with a focus on those impacted by COVID-19. Analyses from their insights can help researchers better understand healthcare and outcomes across de-identified populations. The second...
